Use of circulating tumour DNA to prospectively guide a switch from targeted to immune therapy in BRAF mutant advanced melanoma: the randomised phase II CAcTUS trial
7d ago· 1 min readNews
Source
Exploring 21 patients with BRAF mutant melanoma, the CAcTUS trial tests therapy switch: TT or CPI, then alternative at progression; potential improved long-term survival. PMID:42168180, Nat Commun 2026, @NatureComms #Medsky #Pharmsky #RNA #ASHG #ESHG 🧪
You might also wanna read
Avacta Therapeutics presents platform-validating data for faridoxorubicin in salivary gland cancer at BIO International Conference
Avacta Therapeutics announced platform-validating clinical data for faridoxorubicin (AVA6000), a tumor-activated oncology drug using its pre

AI-guided discovery identifies GPNMB as promising CAR T cell target for multiple cancers
Researchers developed an AI-driven framework for discovering CAR T cell therapy targets by integrating single-cell RNA sequencing data from
cell.com·5d ago
Galleri Blood Test Shows Promise in Detecting 50 Types of Cancer in Large Clinical Trial
A large-scale clinical trial of the Galleri blood test, which detects cancer DNA fragments in blood, showed promising results with 25,000 pa
Spanish Researchers Develop Breakthrough Therapy Protocol for Pancreatic Cancer Treatment
Spanish researchers have developed a new therapy protocol that could revolutionize pancreatic cancer treatment. Pancreatic cancer is notorio
Ask HN: What is the latest on treatment of Metastatic Breast Cancer?
news.ycombinator.com·1y ago
The case for and against universal newborn DNA sequencing
A brief article about Freddie, a baby diagnosed with retinoblastoma (eye cancer) at four weeks old, who was successfully treated with chemot

Comments
Sign in to join the conversation.
No comments yet. Be the first.